Bifogade filer
Kurs & Likviditet
Prenumeration
Kalender
2025-02-14 | Bokslutskommuniké 2024 |
2024-11-08 | Kvartalsrapport 2024-Q3 |
2024-08-23 | Kvartalsrapport 2024-Q2 |
2024-05-24 | Ordinarie utdelning COMBI 0.00 SEK |
2024-05-23 | Årsstämma 2024 |
2024-05-17 | Kvartalsrapport 2024-Q1 |
2024-02-16 | Bokslutskommuniké 2023 |
2023-11-10 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-05-26 | Ordinarie utdelning COMBI 0.00 SEK |
2023-05-25 | Årsstämma 2023 |
2023-05-12 | Kvartalsrapport 2023-Q1 |
2023-02-17 | Bokslutskommuniké 2022 |
2022-11-11 | Kvartalsrapport 2022-Q3 |
2022-08-25 | Kvartalsrapport 2022-Q2 |
2022-05-20 | Ordinarie utdelning COMBI 0.00 SEK |
2022-05-19 | Årsstämma 2022 |
2022-05-12 | Kvartalsrapport 2022-Q1 |
2022-02-17 | Bokslutskommuniké 2021 |
2021-11-12 | Kvartalsrapport 2021-Q3 |
2021-08-20 | Kvartalsrapport 2021-Q2 |
2021-06-07 | Split COMBI 20:1 |
2021-05-26 | Ordinarie utdelning COMBI 0.00 SEK |
2021-05-25 | Årsstämma 2021 |
2021-05-12 | Kvartalsrapport 2021-Q1 |
2021-02-17 | Bokslutskommuniké 2020 |
2020-11-13 | Kvartalsrapport 2020-Q3 |
2020-08-21 | Kvartalsrapport 2020-Q2 |
2020-06-30 | Ordinarie utdelning COMBI 0.00 SEK |
2020-06-29 | Årsstämma 2020 |
2020-05-14 | Kvartalsrapport 2020-Q1 |
2020-02-13 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-21 | Kvartalsrapport 2019-Q2 |
2019-05-17 | Kvartalsrapport 2019-Q1 |
2019-05-16 | Årsstämma 2019 |
2019-05-15 | Ordinarie utdelning COMBI 0.00 SEK |
2019-02-14 | Bokslutskommuniké 2018 |
2018-08-22 | Kvartalsrapport 2018-Q2 |
2018-05-04 | Ordinarie utdelning COMBI 0.00 SEK |
2018-05-03 | Kvartalsrapport 2018-Q1 |
2018-05-03 | Årsstämma 2018 |
2018-01-29 | Bokslutskommuniké 2017 |
2017-11-01 | Kvartalsrapport 2017-Q3 |
2017-08-17 | Kvartalsrapport 2017-Q2 |
2017-05-18 | Kvartalsrapport 2017-Q1 |
2017-05-10 | Ordinarie utdelning COMBI 0.00 SEK |
2017-05-09 | Årsstämma 2017 |
2017-01-31 | Bokslutskommuniké 2016 |
2017-01-26 | Extra Bolagsstämma 2017 |
2016-11-17 | Kvartalsrapport 2016-Q3 |
2016-08-17 | Kvartalsrapport 2016-Q2 |
2016-05-19 | Kvartalsrapport 2016-Q1 |
2016-04-05 | Ordinarie utdelning COMBI 0.00 SEK |
2016-04-04 | Årsstämma 2016 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-11-19 | Kvartalsrapport 2015-Q3 |
2015-08-20 | Kvartalsrapport 2015-Q2 |
Read CombiGene´s newsletter Ingeneious in English
https://issuu.com/pub10/docs/combigene_ingeneious__2019?e=0
Or download the attachment.
Contacts
Jan Nilsson, CEO
Phone: +46 (0)704 66 31 63
Email: jan.nilsson@combigene.com
www.combigene.com
CombiGene AB (publ) Medicon Village, SE-223 81 Lund, Sweden
info@combigene.com
About Us
CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden. The company is public and listed on the Swedish marketplace Nasdaq First North and the company’s Certified Advisor is FNCA Sweden AB, +46 (0)852 80 03 99 info@fnca.se . For further information, please visit www.combigene.com.
CombiGene’s lead project CG01 has received funding from the European Union’s Horizon 2020 research and innovation programme